Inner Mongolia People’s Hospital  | China

Li Na is a dedicated researcher at Inner Mongolia People’s Hospital in Hohhot, China, recognised for her contributions to clinical pharmacology and evidence-based medicine. Her academic background in medicine and pharmacology has provided a strong foundation for her work in translational research focused on improving therapeutic outcomes for neurological and cardiovascular diseases. Professionally, she has been involved in advanced clinical investigations, particularly systematic reviews and meta-analyses assessing the efficacy and safety of pharmacological interventions such as fingolimod in acute ischemic stroke. Her research interests span drug efficacy evaluation, neuroprotective mechanisms, and the integration of novel pharmacotherapies into clinical practice. Skilled in biostatistics, data synthesis, and the use of analytical tools for evidence evaluation, she demonstrates a methodical and data-driven approach to medical research. With several publications indexed in Scopus and a growing citation record, she maintains an active academic profile and collaborates with national and international teams. Her work has earned recognition within the field, reflecting both scientific rigour and clinical relevance. Committed to advancing modern pharmacology and patient care, Li Na continues to bridge clinical insight with research innovation, contributing meaningfully to the evolving landscape of pharmacological science and translational medicine.